Related Experiment Videos
Central serous chorioretinopathy complicating systemic corticosteroid therapy
1Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
European Journal of Ophthalmology
|July 1, 1997
Summary
Systemic corticosteroid therapy may trigger central serous chorioretinopathy (CSCR). Discontinuation of steroids led to spontaneous recovery in a patient with idiopathic thrombocytopenic purpura, suggesting cortisol
Area of Science:
- Ophthalmology
- Endocrinology
Background:
- Systemic corticosteroid use is common for various inflammatory and autoimmune conditions.
- Central serous chorioretinopathy (CSCR) is a condition affecting vision, primarily in younger males.
Observation:
- A case study of a 20-year-old male with idiopathic thrombocytopenic purpura undergoing systemic corticosteroid treatment (100 mg daily) was analyzed.
- The patient presented with symptoms and diagnosis of central serous chorioretinopathy.
Findings:
- The patient was diagnosed with central serous chorioretinopathy during corticosteroid therapy.
- Upon cessation of steroid treatment, the patient experienced spontaneous recovery from CSCR.
Implications:
- This case suggests a potential causal link between systemic corticosteroid administration and the development of central serous chorioretinopathy.
- Further research into the role of cortisol in CSCR pathogenesis is warranted.
- Clinicians should consider corticosteroid-induced CSCR in patients presenting with characteristic retinal findings.